{"date":"2025-09-22","count":8,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-6794-2025-09-22-1811-1cr188h","company_id":"6794","company":"向榮生技","market":"上市","industry":"生技醫療","date":"2025-09-22","time":"18:11:36","subject":"公告本公司股票改列上市前現金增資委託代收價款及存儲價款專戶機構","clause":"第51款","fact_date":"2025-09-22","cite_as":"公開資訊觀測站重大訊息：向榮生技（6794），2025-09-22 18:11，「公告本公司股票改列上市前現金增資委託代收價款及存儲價款專戶機構」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6576-2025-09-22-1807-1alu4c4","company_id":"6576","company":"逸達","market":"上櫃","industry":"生技醫療","date":"2025-09-22","time":"18:07:33","subject":"公告本公司私募有價證券收足股款暨增資基準日","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：逸達（6576），2025-09-22 18:07，「公告本公司私募有價證券收足股款暨增資基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4190-2025-09-22-1709-iz5jz5","company_id":"4190","company":"佐登-KY","market":"上市","industry":"生技醫療","date":"2025-09-22","time":"17:09:12","subject":"本公司修訂「中華民國境內第三次無擔保轉換公司債發行及轉換辦法」之債權人異議期間屆滿公告","clause":"第51款","fact_date":"2025-09-22","cite_as":"公開資訊觀測站重大訊息：佐登-KY（4190），2025-09-22 17:09，「本公司修訂「中華民國境內第三次無擔保轉換公司債發行及轉換辦法」之債權人異議期間屆滿公告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6461-2025-09-22-1653-sqgrt0","company_id":"6461","company":"益得","market":"上櫃","industry":"生技醫療","date":"2025-09-22","time":"16:53:29","subject":"公告本公司法人董事代表人異動","clause":"第6款","fact_date":"2025-09-22","cite_as":"公開資訊觀測站重大訊息：益得（6461），2025-09-22 16:53，「公告本公司法人董事代表人異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6569-2025-09-22-1615-10jca0t","company_id":"6569","company":"醫揚","market":"上櫃","industry":"生技醫療","date":"2025-09-22","time":"16:15:13","subject":"本公司受邀參加凱基證券舉辦之法人說明會","clause":"第12款","fact_date":"2025-09-24","cite_as":"公開資訊觀測站重大訊息：醫揚（6569），2025-09-22 16:15，「本公司受邀參加凱基證券舉辦之法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4172-2025-09-22-1504-7rzr08","company_id":"4172","company":"因華","market":"興櫃","industry":"生技醫療","date":"2025-09-22","time":"15:04:50","subject":"公告本公司法人董事指派代表人","clause":"第6款","fact_date":"2025-09-22","cite_as":"公開資訊觀測站重大訊息：因華（4172），2025-09-22 15:04，「公告本公司法人董事指派代表人」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7799-2025-09-22-1346-1hq46xz","company_id":"7799","company":"禾榮科","market":"上市","industry":"生技醫療","date":"2025-09-22","time":"13:46:44","subject":"公告本公司上市掛牌首五個營業日穩定價格操作結果","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：禾榮科（7799），2025-09-22 13:46，「公告本公司上市掛牌首五個營業日穩定價格操作結果」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6926-2025-09-22-1000-1fqkmsr","company_id":"6926","company":"聖安生醫","market":"興櫃","industry":"生技醫療","date":"2025-09-22","time":"10:00:16","subject":"澄清媒體報導","clause":"第26款","fact_date":"2025-09-22","cite_as":"公開資訊觀測站重大訊息：聖安生醫（6926），2025-09-22 10:00，「澄清媒體報導」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}